Vaxart (VXRT) Accumulated Expenses (2012 - 2026)
Vaxart (VXRT) recorded Accumulated Expenses of $43.13 million in Q2 2026, up 20.7% from $35.73 million a year earlier and up 18.1% from the prior quarter.
Powered by 
Analysis
Vaxart (VXRT) Accumulated Expenses (2012 - 2026) Analysis & Trends
At the end of FY2025, Vaxart reported Accumulated Expenses of $47.88 million, up 320.8% from FY2024.
- Annual Accumulated Expenses has a five-year compound annual growth rate of 58.4% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $11.38 million in FY2024 (+102.0%), $5.63 million in FY2023 (-30.3%), $8.08 million in FY2022 (+59.6%) and $5.06 million in FY2021 (+5.5%).
- Quarterly Accumulated Expenses has ranged from $4.39 million in Q3 2021 to $47.88 million in Q4 2025 over the past five years.
- On a year-over-year basis, Accumulated Expenses has increased for nine consecutive quarters, with growth averaging 228.4% over the last eight quarters.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 563.5% in Q3 2025, against a decline of 42.1% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $36.53 million (Q1 2026), $47.88 million (Q4 2025) and $44.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Vaxart | 115.76 Mn | 51.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.13 Mn |
| Mar 31, 2026 | 36.53 Mn |
| Dec 31, 2025 | 47.88 Mn |
| Sep 30, 2025 | 44.88 Mn |
| Jun 30, 2025 | 35.73 Mn |
| Mar 31, 2025 | 9.96 Mn |
| Dec 31, 2024 | 11.38 Mn |
| Sep 30, 2024 | 6.76 Mn |
| Jun 30, 2024 | 6.61 Mn |
| Mar 31, 2024 | 4.98 Mn |
| Dec 31, 2023 | 5.63 Mn |
| Sep 30, 2023 | 5.99 Mn |
| Jun 30, 2023 | 6.05 Mn |
| Mar 31, 2023 | 6.98 Mn |
| Dec 31, 2022 | 8.08 Mn |
| Sep 30, 2022 | 10.34 Mn |
| Jun 30, 2022 | 8.44 Mn |
| Mar 31, 2022 | 5.10 Mn |
| Dec 31, 2021 | 5.06 Mn |
| Sep 30, 2021 | 4.39 Mn |
API Access
Vaxart Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VXRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "VXRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VXRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();